Global law firm Jones Day has announced that Andrew Rankine has joined the firm’s intellectual property practice as a partner in its Sydney office. Rankine is a patent litigator who focuses on the life sciences sector, and has extensive experience handling complex and high-profile patent disputes for global leaders in the pharmaceutical, biotechnology, and medical device industries. His client work has also involved navigating Australia’s regulatory regime for therapeutic goods as well as the country’s Commonwealth Government reimbursement system, the Pharmaceutical Benefits Scheme. He has counseled numerous life sciences companies on IP portfolio management, freedom to operate, patent validity, patent term extensions, and related matters. “Andrew comes to Jones Day with successful experience working on complicated patent disputes across multiple industry sectors,” said Anthony M. Insogna, who leads the firm’s global IP practice. “That experience will benefit Jones Day clients that operate in Australia where patent disputes play a crucial role in the life sciences sector.”